This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
n11http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33341957
rdf:type
wikibase:Item
schema:description
mokslinis straipsnis 2002年论文 мақолаи илмӣ 2002年論文 artykuł naukowy artigo científico (publicado na 2002) bilimsel makale wissenschaftlicher Artikel artículo científico publicado en 2002 سائنسی مضمون 2002年論文 مقالة علمية articolo scientifico 2002 nî lūn-bûn artikulong pang-agham vitenskapelig artikkel научная статья ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2002年论文 scientific article บทความทางวิทยาศาสตร์ 2002年论文 artigo científico (publicado na 2002) 2002年論文 bài báo khoa học tieteellinen artikkeli wetenschappelijk artikel vedecký článok videnskabelig artikel (udgivet 2002) научни чланак επιστημονικό άρθρο artículu científicu espublizáu en 2002 מאמר מדעי scienca artikolo 2002年の論文 vitskapeleg artikkel articol științific naučni članak article scientifique (publié 2002) 2002 թվականի ապրիլին հրատարակված գիտական հոդված tudományos cikk 2002年论文 article científic vědecký článek 2002年论文 научни чланак мақолаи илмӣ 2002年论文 teaduslik artikkel სამეცნიერო სტატია artigo científico vetenskaplig artikel наукова стаття, опублікована у квітні 2002 2002年論文 2002년 논문 artikull shkencor научна статия 2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած 2002年論文 article scientific مقالهٔ علمی
p:P577
wds:Q33341957-67DA8B80-74C6-495C-9A85-59EFBFED5F75
wdt:P577
2002-04-01T00:00:00Z
p:P407
wds:Q33341957-6C52BE80-3130-4F7E-8A51-DB843807B4C6
wdt:P407
wd:Q1860
p:P2093
wds:Q33341957-AD519538-F5E1-41E1-B06E-83B953886C38 wds:Q33341957-B2709BE0-4169-416C-B97F-604E1476D879 wds:Q33341957-8034735B-8DF5-47EE-82D0-BE7A34A0FF0A wds:Q33341957-A1E69C23-5D1C-4AC7-B792-356C9C483890 wds:Q33341957-674B8770-DA40-46A0-96E9-8B299A993762 wds:Q33341957-5705D4C7-288C-47FD-A8D1-955E83E2CDCE wds:Q33341957-6D4F75A5-F50B-4BBA-B364-0129A20E0551 wds:Q33341957-32930869-3E9B-4E30-AD66-4F5DE8C9E0FE wds:Q33341957-44E842BE-A4EE-42D9-A643-262022635AD3 wds:Q33341957-4BC5CCDC-4940-42AA-95D8-EF35A520AD70
wdt:P2093
T Hickish P Ross P Harper M Nicolson A Norman T Price T Iveson F Lofts H Anderson M Seymour
rdfs:label
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
skos:prefLabel
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
schema:name
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
p:P50
wds:Q33341957-1DBACB04-E189-4CB4-A66E-2059FA9D4C53 wds:Q33341957-67176473-5787-4CBA-8346-759481806EC3 wds:Q33341957-69DF3A53-1230-4CA6-AD95-81A045567B66
wdt:P50
wd:Q92092135 wd:Q38803238 wd:Q37830751
p:P1476
wds:Q33341957-0DCD8DDC-FF11-4866-8A6E-8D7257AE9B32
wdt:P1476
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
p:P304
wds:Q33341957-FB974E29-C576-4949-AC9D-8757E6188EE5
wdt:P304
1996-2004
p:P31
wds:Q33341957-C8C871A7-3295-4551-AF24-052535380BBA
wdt:P31
wd:Q13442814
p:P921
wds:Q33341957-404E6EDD-04A1-4A0C-A99F-3A396536C26B wds:Q33341957-F01F9683-0E46-4565-BDC9-7DABDFB69D40
wdt:P921
wd:Q412415 wd:Q238512
p:P698
wds:Q33341957-18C1CDEA-0137-4B2C-80CF-5058A57BA67A
wdtn:P698
n12:11956258
wdt:P698
11956258
p:P1433
wds:Q33341957-F72DEF90-34EA-4D71-ACDE-AF29CA2488D0
wdt:P1433
wd:Q400292
p:P433
wds:Q33341957-2218A594-0EF1-4FDE-856D-95E25F5A42BF
p:P478
wds:Q33341957-444F1A8C-BC5F-4F2C-BC4C-DE1CB4E1A279
wdt:P433
8
wdt:P478
20
p:P356
wds:Q33341957-7E9FB4EB-56C3-4E27-AF8D-F001B6397570
wdtn:P356
n11:JCO.2002.08.105
wdt:P356
10.1200/JCO.2002.08.105